Replimune Group, Inc. (REPL)
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
$751.68M
Mr. Philip Astley-Sparke F.S.A., FSA
206.00
Woburn, MA
Jul 20, 2018
-3.36
$-3.27
3.30
17.06
0.00%
-3.80
0.19
1.35
0.00
16.81
-30.13%
-35.52%
Similar stocks (15)
United Therapeutics Corporation
UTHR
Cerevel Therapeutics Holdings, Inc.
CERE
Nuvalent, Inc.
NUVL
Crinetics Pharmaceuticals, Inc.
CRNX
Protagonist Therapeutics, Inc.
PTGX
Keros Therapeutics, Inc.
KROS
Kura Oncology, Inc.
KURA
Syndax Pharmaceuticals, Inc.
SNDX
PureTech Health plc
PRTC
Gossamer Bio, Inc.
GOSS
Ventyx Biosciences, Inc.
VTYX
Nuvectis Pharma, Inc.
NVCT
Kronos Bio, Inc.
KRON
Aerovate Therapeutics, Inc.
AVTE
Lyra Therapeutics, Inc.
LYRA
ETF Exposure (40)
Loncar Cancer Immunotherapy ETF
CNCR
3.54%
Listed Funds Trust - Horizon Kinetics Medical ETF
MEDX
0.84%
iShares Micro-Cap ETF
IWC
0.14474%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.064%
iShares Biotechnology ETF
IBB
0.05236%
iShares Russell 2000 Value ETF
IWN
0.04158%
Vanguard Russell 2000 Value Index Fund
VTWV
0.04%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.028%
iShares Russell 2000 ETF
IWM
0.02099%
Vanguard Russell 2000 Index Fund
VTWO
0.02%
ProShares Ultra Nasdaq Biotechnology
BIB
0.018990103903001463%
Dimensional U.S. Small Cap ETF
DFAS
0.01575987%
Schwab U.S. Small-Cap ETF
SCHA
0.0136595984%
Vanguard Health Care Index Fund
VHT
0.01%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
ProShares Ultra Russell2000
UWM
0.007986360027416007%
Dimensional U.S. Core Equity 2 ETF
DFAC
0.006714240000000001%
Fidelity MSCI Health Care Index ETF
FHLC
0.0057204299999999994%
ALPS Medical Breakthroughs ETF
SBIO
0.0046%
ProShares UltraPro Russell2000
URTY
0.003937067984683588%
ProShares Hedge Replication ETF
HDG
0.003348475866157473%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00127%
Schwab U.S. Broad Market ETF
SCHB
8.830878e-4%
iShares Russell 3000 ETF
IWV
7.8e-4%
SPDR Portfolio MSCI Global Stock Market ETF
SPGM
7.76e-4%
Dimensional U.S. Targeted Value ETF
DFAT
6.1673e-4%
Dimensional US Core Equity Market ETF
DFAU
4.0105e-4%
Dimensional U.S. Equity ETF
DFUS
2.1608e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Quantitative Funds - Vanguard Growth and Income Fund
VGIAX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Growth and Income Fund
VQNPX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Similar stocks (15)
United Therapeutics Corporation
UTHR
Cerevel Therapeutics Holdings, Inc.
CERE
Nuvalent, Inc.
NUVL
Crinetics Pharmaceuticals, Inc.
CRNX
Protagonist Therapeutics, Inc.
PTGX
Keros Therapeutics, Inc.
KROS
Kura Oncology, Inc.
KURA
Syndax Pharmaceuticals, Inc.
SNDX
PureTech Health plc
PRTC
Gossamer Bio, Inc.
GOSS
Ventyx Biosciences, Inc.
VTYX
Nuvectis Pharma, Inc.
NVCT
Kronos Bio, Inc.
KRON
Aerovate Therapeutics, Inc.
AVTE
Lyra Therapeutics, Inc.
LYRA
ETF Exposure (40)
Loncar Cancer Immunotherapy ETF
CNCR
3.54%
Listed Funds Trust - Horizon Kinetics Medical ETF
MEDX
0.84%
iShares Micro-Cap ETF
IWC
0.14474%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.064%
iShares Biotechnology ETF
IBB
0.05236%
iShares Russell 2000 Value ETF
IWN
0.04158%
Vanguard Russell 2000 Value Index Fund
VTWV
0.04%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.028%
iShares Russell 2000 ETF
IWM
0.02099%
Vanguard Russell 2000 Index Fund
VTWO
0.02%
ProShares Ultra Nasdaq Biotechnology
BIB
0.018990103903001463%
Dimensional U.S. Small Cap ETF
DFAS
0.01575987%
Schwab U.S. Small-Cap ETF
SCHA
0.0136595984%
Vanguard Health Care Index Fund
VHT
0.01%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
ProShares Ultra Russell2000
UWM
0.007986360027416007%
Dimensional U.S. Core Equity 2 ETF
DFAC
0.006714240000000001%
Fidelity MSCI Health Care Index ETF
FHLC
0.0057204299999999994%
ALPS Medical Breakthroughs ETF
SBIO
0.0046%
ProShares UltraPro Russell2000
URTY
0.003937067984683588%
ProShares Hedge Replication ETF
HDG
0.003348475866157473%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.00127%
Schwab U.S. Broad Market ETF
SCHB
8.830878e-4%
iShares Russell 3000 ETF
IWV
7.8e-4%
SPDR Portfolio MSCI Global Stock Market ETF
SPGM
7.76e-4%
Dimensional U.S. Targeted Value ETF
DFAT
6.1673e-4%
Dimensional US Core Equity Market ETF
DFAU
4.0105e-4%
Dimensional U.S. Equity ETF
DFUS
2.1608e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Quantitative Funds - Vanguard Growth and Income Fund
VGIAX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Growth and Income Fund
VQNPX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%